Viewing Study NCT02350569

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2026-02-20 @ 6:35 PM
Study NCT ID: NCT02350569
Status: COMPLETED
Last Update Posted: 2018-11-19
First Post: 2015-01-26
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
Sponsor: Gilead Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C Virus Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None liver transplant View
None hepatitis C View
None Gilead View
None Communicable Diseases View
None Infection View
None Liver Diseases View
None RNA Virus Infections View